Specify a stock or a cryptocurrency in the search bar to get a summary
BioMark Diagnostics Inc
20BBiomark Diagnostics Inc., an oncology focused company, develops cancer diagnostic platform to detect, monitor, and treat cancer. The company invests in and develops liquid biopsy metabolic panel assay for early stage diagnosis of lung cancer. It has a strategic partnership with Rubix LS to develop diagnostic tools to enhance lung cancer screening and improve breast cancer screening program for women with dense breasts. The company was incorporated in 2014 and is headquartered in Richmond, Canada. Address: 3851 Shell Road, Richmond, BC, Canada, V6X 2W2
Analytics
WallStreet Target Price
–P/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 20B
Dividend Analytics 20B
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 20B
Stock Valuation 20B
Financials 20B
Results | 2019 | Dynamics |